Physiological redox conversion of alpha-hydroxy/keto acids is believed to be reversibly carried out by (de)hydrogenases, employing nicotinamide cofactors. With lactate dehydrogenase (LDH) as example, we point out that while the utilization of NADH for the reduction of pyruvate to lactate (the post-glycolytic reaction) can be mediated via the classical Michaelis-Menten mechanism, the oxidation of lactate to pyruvate (with or without the uphill reduction of NADH) necessitates alternative physiological approaches. This reaction could be more efficiently coupled/catalyzed with/by murzyme activities, which employ diffusible reactive (oxygen) species (DRS/DROS/ROS). Such a scheme would enable the cellular system to tide over the unfavorable energy barriers of the forward reaction (~450 kJ/mol; earlier considered to be ~25 kJ/mole!), and give kinetically viable conversions. Further, the new mechanism does not necessitate any ‘smart decision-making’ by the pertinent redox isozyme(s). For LDH, the new theory explains its multimeric nature, non-variant structure of the isozymes’ active sites and accounts for why lactate is transported to the liver for further utilization within the physiological purview of Cori cycle. The theoretical insights, in silico evidence and analyses of literature herein also enrich our understanding of ‘lactic acidosis’ (in clinical context), Warburg effect and approach for cancer therapy.